Akili is building clinically validated cognitive therapeutics, assessments and diagnostics that look and feel like high-quality video games. Leveraging medical-grade science and consumer-grade software technology, the company is seeking to produce a new type of healthcare product that is both highly-effective and highly-engaging. The company was founded by PureTech Health, together with leading neuroscientists and game designers. Akili has garnered investment from Shire PLC and has strategic partnerships with Pfizer Inc. and Autism Speaks.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/09/18 | $13,000,000 | Series C |
Amgen Business Development Baillie Gifford Brooklands Capital Strategies Canepa Advanced Healthcare Fund CLSA Digital Garage Fearless Ventures Jazz Venture Partners M Ventures Omidyar Technology Ventures Temasek  | undisclosed |
